8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-051455
Material agreement · New debt or obligation · Unregistered share sale · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading v355360_8k.htm…